Anti Inflammatory News and Research

RSS
Biovista's BVA-201 drug for MS shows positive results

Biovista's BVA-201 drug for MS shows positive results

Caldolor launched ahead of schedule in U.S. by Cumberland Pharmaceuticals

Caldolor launched ahead of schedule in U.S. by Cumberland Pharmaceuticals

AOLS to initiate clinical study for testing the efficacy of AEOL 10150

AOLS to initiate clinical study for testing the efficacy of AEOL 10150

BioElectronics to file for FDA pre-marketing clearance of its ActiPatch Therapy product

BioElectronics to file for FDA pre-marketing clearance of its ActiPatch Therapy product

Teva Pharmaceutical Industries to present MS treatment research data

Teva Pharmaceutical Industries to present MS treatment research data

Can-Fite's Phase II clinical study of CF101 provides positive results

Can-Fite's Phase II clinical study of CF101 provides positive results

Biotechnological approach to fight H1N1 influenza

Biotechnological approach to fight H1N1 influenza

Results of Phase 2 rheumatoid arthritis clinical trial announced

Results of Phase 2 rheumatoid arthritis clinical trial announced

Endo Pharmaceuticals launches VALSTAR for treating recurrent carcinoma in situ bladder tumors

Endo Pharmaceuticals launches VALSTAR for treating recurrent carcinoma in situ bladder tumors

Ecological catalysts to get ibuprofen and naxopren from oil production

Ecological catalysts to get ibuprofen and naxopren from oil production

Biogen Idec's MS franchise to present at the 25th Congress of ECTRIMS

Biogen Idec's MS franchise to present at the 25th Congress of ECTRIMS

FDA extends review period for Endo Pharmaceuticals' testosterone undecanoate

FDA extends review period for Endo Pharmaceuticals' testosterone undecanoate

Study identifies key compound that quickens recovery from life-threatening blood cell shortages

Study identifies key compound that quickens recovery from life-threatening blood cell shortages

Pfizer to pay $2.3 billion for health care fraud settlement

Pfizer to pay $2.3 billion for health care fraud settlement

LifeVantage granted third patent for Protandim

LifeVantage granted third patent for Protandim

Nuvo Research's co-operative drug development project with Fraunhofer Institute for developing WF10

Nuvo Research's co-operative drug development project with Fraunhofer Institute for developing WF10

Researchers analyze the role of bioactive lipids in inflammatory diseases

Researchers analyze the role of bioactive lipids in inflammatory diseases

New Drug Application for VIMOVO accepted by U.S. Food and Drug Administration

New Drug Application for VIMOVO accepted by U.S. Food and Drug Administration

Forest Laboratories announces phase 3 trial results for roflumilast

Forest Laboratories announces phase 3 trial results for roflumilast

Study reveals effectiveness of BioElectronics' ActiPatch therapy device for treating heel and foot pain

Study reveals effectiveness of BioElectronics' ActiPatch therapy device for treating heel and foot pain

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.